Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia 53Lymphoma 51Melanoma 44Breast Neoplasms 37Lymphoma, Follicular 36Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 29Neuroblastoma 28Multiple Myeloma 28Lymphoma, Large B-Cell, Diffuse 25Prostatic Neoplasms 24Lymphoma, Mantle-Cell 23Myelodysplastic Syndromes 22Lymphoma, Large-Cell, Immunoblastic 20Neoplasms, Plasma Cell 19Leukemia, Myeloid, Chronic-Phase 19Lung Neoplasms 18Hodgkin Disease 18Carcinoma, Non-Small-Cell Lung 18Burkitt Lymphoma 18Ovarian Neoplasms 17Lymphoma, B-Cell, Marginal Zone 17Neoplasm Metastasis 16Glioblastoma 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Congenital Abnormalities 15Leukemia, Myeloid, Accelerated Phase 14Colorectal Neoplasms 13

Interventions

Temozolomide 15Radiotherapy 11Everolimus 6Bevacizumab 6Irinotecan 5Cyclophosphamide 5ribociclib 4Radiation 4Panobinostat 4TIC10 compound 3Specimen Handling 3Re-Irradiation 3Etoposide 3Dasatinib 3pembrolizumab 2nimotuzumab 2abemaciclib 2Vorinostat 2Valproic Acid 2Topotecan 2Nivolumab 2Mebendazole 2Magnetic Resonance Spectroscopy 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gemcitabine 2GDC-0084 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cilengitide 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × sargramostim × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡